期刊文献+

生存素反义寡核苷酸在胃癌化疗中对表阿霉素的增敏性及其信号转导途径研究

Enhancement of cytotoxic effect of epirubicin on gastric carcinoma cell line SGC-7901 by survivin antisense RNA and signaling pathway
下载PDF
导出
摘要 目的:通过构建survivin反义寡核苷酸,研究其在胃癌化疗中对表阿霉素(Epirubicin,EPI)的增敏作用及作用机制。方法:构建survivin反义寡核苷酸链(Antiscnse RNA,ASODN)及正义寡核苷酸对照链(SODN),脂质体法转染胃癌SGC-7901细胞,MTT法检测转染组细胞抑制率并筛选出适宜浓度,不同浓度表阿霉素处理胃癌SGC-7901细胞,MTT法检查表阿霉素对其生长抑制作用并筛选出4组浓度做为待测浓度,将2种因素联合作用于SGC-7901细胞,Western-blot法检查survivin蛋白表达情况,MTT法检查表阿霉素对其抑制率,流式细胞仪检查细胞周期,Annexin V-FITC法检查细胞凋亡情况,RT-PCR法检查bcl-2、SMac mRNA表达情况。结果:经200nmol/L survivin反义寡核苷酸处理后的SGC-7901细胞对表阿霉素的敏感性明显增加:MTT法示转染后细胞经表阿霉素作用24h后,抑制率较单独使用表阿霉素的未转染组明显提高(P<0.05,q>1.15),流式细胞仪检查示联合作用组使细胞G2/M期细胞数较单独使用表阿霉素组明显增多:Western-blot检查示转染后survivin蛋白表达水平显著降低,Annexin V-FITC检查示转染组细胞凋亡明显增加,RT-PCR检查示:SMac mRNA在联合作用组较空白对照组表达上调。结论:Survivin反义寡核苷酸能够增强SGC-7901细胞对表阿霉素的敏感性,其作用可能是通过上调SMac的表达实现的。 Objective: To investigate whether interfering survivin has the potential to sensitize stomach cancer cells to Epirubicin. Methods: By the method of liposome transfection, survivin antisense oligodeoxynucleotide was transfected into human stomach cancer SGC-7901 cell line. Treat cells with different concentrations of survivin ASODN and Epirubicin respectively to select the best combination trough assessing the growth of cells by MTT assay. Cells were randomly divided into control group,ASODN group, Epirubicin and combination group. Western blot analysis was used to check the survivin protein expression;inhibitive rate were detected by MTT assay; Flow cytometric analysis was used to detect the cycle status of SGC-7901 cells. The apoptosis was screened according to the result of Annexin V-FITC. Reverse transcription polymerase chain reaction( RT-PCR )were applied to detect the expression of bcl-2 ,SMac mRNA. Results: MTF assay showed the proliferation of SGC-7901 cells was retarded obviously contrasting to control group. The level of survivin protein expression in ASODN group are lower than control group according to Western blot analysis. Annexin V-FITC show that the apoptosis rate of ASODN group cells increases . The level of SMac mRNA expression in ASODN group are higher than control group according to RT-PCR analysis. Conclusion: Survivin siRNA can sensitize stomach cancer cells to Epirubicin. Up-regulating the SMac expression might be one of mechanisms.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2009年第5期570-574,共5页 Journal of Chongqing Medical University
关键词 反义寡核苷酸 生存素 表阿霉素 信号转导途径 Antisense RNA Survivin Epirubicin Signaling pathway
  • 相关文献

参考文献11

  • 1涂正生,彭小娟,刑军,李国华.SGC7901细胞对化疗药物的敏感性研究[J].江西医学院学报,2007,47(1):84-86. 被引量:2
  • 2Chandele A, Prasad V, Jagtap J C,et al. Upregulation of Survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis[J]. Neoplasia, 2004,6( 1 ) : 29-40.
  • 3吴裕丹,陈燕,陈文娟,何明生,董继华.γ-干扰素对姜黄素抑制HL-60细胞增殖的影响[J].癌症,1999,18(6):635-638. 被引量:12
  • 4Altieri D C.Survivin in apoptosis control and cell cycle regulation in cancer[J].Prog Cell Cycle Res, 2003,5 : 447-452.
  • 5Mahotka C,Wenzel M,Springer E,et al. Survivin-deltaEx3 and survivin-2B : two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties[J]. Cancer Res, 1999,59 ( 24 ) : 6097-6102.
  • 6Cohen C,Lohmann C M,Cotsonis G,et al. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis[J]. Mod Pathol, 2003,16( 6 ) : 574-583.
  • 7Zaffaroni N, Daidone M G. Survivin expression and resistance to anticancer treatments:perspectives for new therapeutic interventions [J]. Drug Resist Updat,2002,5(2) :65.
  • 8Verhagen A M,Ekert P G,Pakusch M,et al. Identification of DIABLO, A mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins [J]. Cell, 2000,102( 1 ) : 43-53.
  • 9Kashkar H, Haefs C. XIAP-mediated caspase inhibition in Hodgkin ' s lymphoma derived B cells[J]. J Exp Med, 2003,198 ( 2 ) : 341-347.
  • 10Bafaloukos D,Bozas G,Kalofonos H,et al. Paclitaxel,epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: A Hellenic Cooperative Oncology Group(HeCOG) study[J]. Gynecol Oncol, 2008, 110( 1 ) :87-92.

二级参考文献15

  • 1吴裕丹,同济医科大学学报,1999年,28卷,299页
  • 2Kuo M L,Biochem Biophys Acta,1996年,1317卷,95页
  • 3Zhang K,Biochem Biophys Res Commun,1994年,200卷,522页
  • 4陈燕,中华血液学杂志,1991年,12卷,30页
  • 5唐佩弦,造血细胞培养技术,1985年,93页
  • 6Ma Y,Zhang M,Wang C J,et al.Extensive Lymphedenectomy Can Improve Prognosis of Gastric Cancer[J].CJCP,2001,1(2):86-90.
  • 7Pezet D,Michel P,Rebischung C,et al.Cancer of the Stomach[J].Gastroenterol Clin Biol,2006,2:S2516-S2523.
  • 8Msika S,Benhamiche A M,Jouve J L,et al.Prognostic Factors After Curative Resection for Gastric Cancer.Apopulation-based Study[J].Eur J Cancer,2000,36(3):390-396.
  • 9Doglietto G B,Pacell I F,Caprino P,et al.Surgery:Independent Prognostic Factor Incurable and Far Advanced Gastric Cancer[J].World J Surg,2000,24(4):459-463.
  • 10Hecht J R.Adjuvant Therapy for Gastric Cancer:A Reality at Last[J].Curr Gastroenterol Rep,2000,2(6):478-481.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部